Literature DB >> 17179666

Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene.

Kenta Shimizu1, Naoto Ito, Makoto Sugiyama, Nobuyuki Minamoto.   

Abstract

The growth of a virulent strain of fixed rabies virus, Nishigahara, in mouse neuroblastoma NA cells treated with type I interferon (IFN) was compared with that of a derivative avirulent strain, Ni-CE. Nishigahara strain was slightly sensitive to IFN treatment but still grew more efficiently than did Ni-CE strain in IFN-treated NA cells. Furthermore, a virulent chimeric virus with the phosphoprotein gene from Nishigahara strain in the Ni-CE genome was less sensitive to IFN treatment than was Ni-CE strain, indicating that the IFN sensitivity is determined by the phosphoprotein gene of the virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179666     DOI: 10.1111/j.1348-0421.2006.tb03875.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  11 in total

1.  Conservation of a unique mechanism of immune evasion across the Lyssavirus genus.

Authors:  L Wiltzer; F Larrous; S Oksayan; N Ito; G A Marsh; L F Wang; D Blondel; H Bourhy; D A Jans; G W Moseley
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

2.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

3.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

4.  Roles of the Rabies Virus Phosphoprotein Isoforms in Pathogenesis.

Authors:  Kazuma Okada; Naoto Ito; Satoko Yamaoka; Tatsunori Masatani; Hideki Ebihara; Hideo Goto; Kento Nakagawa; Hiromichi Mitake; Kota Okadera; Makoto Sugiyama
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

5.  Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response.

Authors:  Tatsunori Masatani; Naoto Ito; Kenta Shimizu; Yuki Ito; Keisuke Nakagawa; Yoshiharu Sawaki; Hiroyuki Koyama; Makoto Sugiyama
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

6.  Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity.

Authors:  Guillaume Castel; Mohamed Chtéoui; Grégory Caignard; Christophe Préhaud; Stéphanie Méhouas; Eléonore Réal; Corinne Jallet; Yves Jacob; Rob W H Ruigrok; Noël Tordo
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

7.  Quantitative Analysis of the Microtubule Interaction of Rabies Virus P3 Protein: Roles in Immune Evasion and Pathogenesis.

Authors:  Aaron Brice; Donna R Whelan; Naoto Ito; Kenta Shimizu; Linda Wiltzer-Bach; Camden Y Lo; Danielle Blondel; David A Jans; Toby D M Bell; Gregory W Moseley
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

Review 8.  Lyssaviruses: current trends.

Authors:  Susan A Nadin-Davis; Christine Fehlner-Gardiner
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

Review 9.  Regulation of nucleocytoplasmic trafficking of viral proteins: an integral role in pathogenesis?

Authors:  Alex J Fulcher; David A Jans
Journal:  Biochim Biophys Acta       Date:  2011-04-16

Review 10.  Subversion of the Immune Response by Rabies Virus.

Authors:  Terence P Scott; Louis H Nel
Journal:  Viruses       Date:  2016-08-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.